The Critical Importance of ePRO (electronic Patient Reported Outcomes) in Clinical Research in Our Challenging and Evolving Time
Paul-André de Lame, M.D., Founder of Anabase International Corp.
Naomi Waithira, Head of Data Management, Mahidol Oxford Research Unit, University of Oxford.
John Woock, Ph.D., Chief Marketing Officer at Axonics Modulation Technologies, Inc.
Andrew Schachter, Founder and Chief Executive Officer of Axiom Real-Time Metrics, Inc.
Taren Grom, Editor, PharmaVOICE (Moderator)
You will want to attend this virtual panel bringing together leaders in clinical development/operations and data management. This expert panel is currently deeply engaged in complex global ePRO studies.
The panel will discuss:
- The critical importance of ePRO/eCOA data in today’s clinical research
- Managing critical end-points in ePRO data
- Best practices in managing ePRO data
- Capturing data in the age of COVID-19
- Potential to understand key aspects of patient data
About the Sponsors
Headquartered in Toronto, Canada, Axiom delivers intuitive, powerful and cost-effective eClinical solutions and services focused around your entire study. Services include: Data Management, Data Analytics, Biostatistics and Pharmacovigilance. Axiom's eClinical suite, Fusion, delivers a powerful range of innovative end-user focused, unified functionality and 15 modules. Axiom serves as the Connected Hub for your entire clinical study data and operational needs. Fusion Delivers: EDC, DM, IWRS, CTMS, Inventory Management, IVR, Patient Portal, AE/SAE Tracking, Safety Database, Central Lab, Imaging, eTMF, and 24/7 Project and Clinical Data Reporting.For more information please visit www.axiommetrics.com/.